This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Exosomes Europe
5-6 June 2024
DoubleTree Tower of London

FiberCell Systems Inc.

Profile

FiberCell Systems Inc. founded in 2000, is the preeminent supplier of hollow fiber bioreactors for laboratory and pre-clinical scale research and bio-production. The 3-D culture conditions provide a more in vivo like environment and can concentrate secreted products such as exosomes by up to 100X. Post-translational modifications are uniform and complete, and cultures can be maintained for many months in a continuous production mode. MSC behave much as they do in vivo. Adaptation to protein free mediums is facilitated, eliminating the requirement for serum. The system is single use, closed and bio-safe. Primary applications include monoclonal antibody and recombinant protein production, exosome generation, antibiotic PK/PD studies and cellular co-cultivation.

www.fibercellsystems.com

We're bringing you

  • Clinical Scale Production of Extracellular Vesicles in a closed, 3-D Perfusion Hollow Fiber Bioreactor

    12:30